title: CCR5 gene polymorphism is a genetic risk factor for radiographic severity of rheumatoid arthritis.
abstract: The chemokine receptor [C-C chemokine receptor 5 (CCR5)] is expressed on diverse immune effecter cells and has been implicated in the pathogenesis of rheumatoid arthritis (RA). This study sought to determine whether single-nucleotide polymorphisms (SNPs) in the CCR5 gene and their haplotypes were associated with susceptibility to and severity of RA. Three hundred fifty-seven patients with RA and 383 healthy unrelated controls were recruited. Using a pyrosequencing assay, we examined four polymorphisms -1118 CTAT(ins) (/del) (rs10577983), 303 A>G (rs1799987), 927 C>T (rs1800024), and 4838 G>T (rs1800874) of the CCR5 gene, which were distributed over the promoter region as well as the 5' and 3' untranslated regions. No significant difference in the genotype, allele, and haplotype frequencies of the four selected SNPs was observed between RA patients and controls. CCR5 polymorphisms of -1118 CTAT(del) (P = 0.012; corrected P = 0.048) and 303 A>G (P = 0.012; corrected P = 0.048) showed a significant association with radiographic severity in a recessive model, and, as a result of multivariate logistic regression analysis, were found to be an independent predictor of radiographic severity. When we separated the erosion score from the total Sharp score, the statistical significance of CCR5 polymorphisms showed an increase; -1118 CTAT(ins) (/del) (P = 0.007; corrected P = 0.028) and 303 A>G (P = 0.007; corrected P = 0.028). Neither SNPs nor haplotypes of the CCR5 gene showed a significant association with joint space narrowing score. These results indicate that genetic polymorphisms of CCR5 are an independent risk factor for radiographic severity denoted by modified Sharp score, particularly joint erosion in RA.
authors.affiliation: Department of Internal Medicine, Daegu Fatima hospital, Daegu, Republic of Korea.
authors.forename: S W
authors.initials: SW
authors.lastname: Han
authors.forename: K H
authors.initials: KH
authors.lastname: Sa
authors.forename: S I
authors.initials: SI
authors.lastname: Kim
authors.forename: S I
authors.initials: SI
authors.lastname: Lee
authors.forename: Y W
authors.initials: YW
authors.lastname: Park
authors.forename: S S
authors.initials: SS
authors.lastname: Lee
authors.forename: W H
authors.initials: WH
authors.lastname: Yoo
authors.forename: J S
authors.initials: JS
authors.lastname: Soe
authors.forename: E J
authors.initials: EJ
authors.lastname: Nam
authors.forename: J
authors.initials: J
authors.lastname: Lee
authors.forename: J Y
authors.initials: JY
authors.lastname: Park
authors.forename: Y M
authors.initials: YM
authors.lastname: Kang
mesh_terms: D020413:3' Untranslated Regions; D020121:5' Untranslated Regions; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000483:Alleles; D001172:Arthritis, Rheumatoid / Q000000981:diagnostic imaging* / Q000235:genetics* / Q000473:pathology; D001175:Arthrography; D016022:Case-Control Studies; D005260:Female; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D006239:Haplotypes; D006801:Humans; D007596:Joints / Q000378:metabolism* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic; D019713:Receptors, CCR5 / Q000235:genetics*; D012307:Risk Factors; D012720:Severity of Illness Index
chemical_list: D020413:3' Untranslated Regions; D020121:5' Untranslated Regions; D019713:Receptors, CCR5